Zhongzhu Healthcare Holding Co.,Ltd (SHA:600568)
2.070
+0.040 (1.97%)
Oct 23, 2026, 3:00 PM CST
SHA:600568 Revenue
Zhongzhu Healthcare Holding Co.,Ltd had revenue of 150.55M CNY in the quarter ending June 30, 2026, a decrease of -6.72%. This brings the company's total for the last twelve months to 533.88M, down -6.74% year-over-year. In the year 2025, Zhongzhu Healthcare Holding Co.,Ltd had annual revenue of 577.34M with 10.73% growth. That makes Zhongzhu Healthcare Holding Co.,Ltd the 24,386th largest company in the world by revenue and 4,363rd in China.
Revenue (ttm)
533.88M
Revenue Growth
-6.74%
P/S Ratio
7.49
Revenue / Employee
452.05K
Employees
1,181
Market Cap
4.00B
Revenue by Segment
- Medical Division 396.10M 67.2%
- Property development division 125.57M 21.3%
- Pharmaceutical and others 62.51M 10.6%
- Financial Leasing Division 5.38M 0.9%
Fiscal year ended Dec 31, 2025 See the full SHA:600568 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 577.34M | 55.96M | 10.73% |
| Dec 31, 2024 | 521.39M | -117.18M | -18.35% |
| Dec 31, 2023 | 638.56M | 132.59M | 26.21% |
| Dec 31, 2022 | 505.97M | -75.09M | -12.92% |
| Dec 31, 2021 | 581.06M | -146.41M | -20.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.18B |
| Jianmin Pharmaceutical Group | 3.12B |
| Jiangsu Lianhuan Pharmaceutical | 3.00B |
| Tianjin Lisheng Pharmaceutical | 1.30B |
| Hunan Hansen Pharmaceutical | 1.01B |
| LanZhou Foci Pharmaceutical | 926.49M |
| Newland Pharmaceutical | 710.55M |
| ChengDa Pharmaceuticals | 479.41M |